Dr. Siegel Discusses RT-Related AEs for Patients With Oropharyngeal Squamous Cell Carcinomas
Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the adverse events (AEs) associated with radiation therapy (RT) for patients with oropharyngeal squamous cell carcinomas.
Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the adverse events (AEs) associated with radiation therapy (RT) for patients with oropharyngeal squamous cell carcinomas.
The standard of care for treating these patients is a combination of weekly low-dose chemotherapy with cisplatin and radiation therapy.
The short-term associated AE with radiation therapy can be difficulty eating. In the long-term, side effects include dry mouth and an altered sense of taste, which lead to implications such as gum disease and jaw bone decay.
